Deal Watch: Medivation Enters Confidential Talks With Suitors, Including Sanofi
Executive Summary
Bristol acquires Swedish biotech Cormorant to bolster its immuno-oncology franchise. Moderna quickly follows up its cancer partnership with another with Vertex to use mRNA approaches to treat cystic fibrosis.